Abiopharma

🔍 Michalek Libor (Director)

Company: Affirm Holdings, Inc. (AFRM)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,336 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 218,113.00 | transaction_form_type: 4
• Sold 1,089 shares of Class A Common Stock at $67.54 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 217,024.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Michalek 2007 Trust dated March 21, 2007 | shares_owned_after: 868,114.00 | Footnotes: F2
• Sold 2,336 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,344.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on May 1, 2026.
• F2: The shares are held by the Michalek 2007 Family Trust dated March 21, 2007. The Reporting Person and his spouse are trustees of the trust.
• F3: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F4: The RSUs vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date.